Teva Pharmaceutical Industries Limited American Depositary Shares Earnings Dividend

Teva Pharmaceutical Industries Limited American Depositary Shares’s revenue fell -0.81% since last year same period to $4142Mn in the Q2 2026. On a quarterly growth basis, Teva Pharmaceutical Industries Limited American Depositary Shares has generated 4.04% jump in its revenue since last 3-months.

Teva Pharmaceutical Industries Limited American Depositary Shares’s net profit fell -304.26% since last year same period to $-576Mn in the Q2 2026. On a quarterly growth basis, Teva Pharmaceutical Industries Limited American Depositary Shares has generated -256.1% fall in its net profits since last 3-months.

Teva Pharmaceutical Industries Limited American Depositary Shares’s net profit margin fell -305.93% since last year same period to -13.91% in the Q2 2026. On a quarterly growth basis, Teva Pharmaceutical Industries Limited American Depositary Shares has generated -250.03% fall in its net profit margins since last 3-months.

Teva Pharmaceutical Industries Limited American Depositary Shares’s earning per share (EPS) estimates for the current quarter stand at 0.05 - a -89.13% fall from last quarter’s estimates.

Teva Pharmaceutical Industries Limited American Depositary Shares’s earning per share (EPS) estimates for the current year stand at 0.05.

Teva Pharmaceutical Industries Limited American Depositary Shares’s earning per share (EPS) fell -3.03% since last year same period to 0.64 in the Q2 2026. This indicates that the Teva Pharmaceutical Industries Limited American Depositary Shares has generated -3.03% annual rate of fall in its earning per share (EPS) in the last 4 quarters.